FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149633685> ?p ?o ?g. }

• W2149633685 endingPage "1206" @default.
• W2149633685 startingPage "1199" @default.
• W2149633685 abstract "Background and objectives People with atherosclerotic renal artery stenosis may benefit from renin-angiotensin inhibitors, angiotensin-converting enzyme inhibitors, and angiotensin-receptor blockers, but little is known about the factors associated with their use. Design, setting, participants, & measurements The Cardiovascular Outcomes in Renal Atherosclerotic Lesions study (ClinicalTrials.gov identified: NCT00081731) is a prospective, international, multicenter clinical trial that randomly assigned participants with atherosclerotic renal artery stenosis who received optimal medical therapy to stenting versus no stenting from May 2005 through January 2010. At baseline, medication information was available from 853 of 931 randomly assigned participants. Kidney function was measured by serum creatinine–based eGFR at a core laboratory. Results Before randomization, renin-angiotensin inhibitors were used in 419 (49%) of the 853 participants. Renin-angiotensin inhibitor use was lower in those with CKD (eGFR<60 ml/min per 1.73 m2) (58% versus 68%; P=0.004) and higher in individuals with diabetes (41% versus 27%; P<0.001). Presence of bilateral renal artery stenosis or congestive heart failure was not associated with renin-angiotensin inhibitor use. Although therapy with renin-angiotensin inhibitors varied by study site, differences in rates of use were not related to the characteristics of the site participants. Participants receiving a renin-angiotensin inhibitor had lower systolic BP (mean±SD, 148±23 versus 152±23 mmHg; P=0.003) and more often had BP at goal (30% versus 22%; P=0.01). Conclusions Kidney function and diabetes were associated with renin-angiotensin inhibitor use. However, these or other clinical characteristics did not explain variability among study sites. Patients with renal artery stenosis who received renin-angiotensin inhibitor treatment had lower BP and were more likely to be at treatment goal." @default.
• W2149633685 created "2016-06-24" @default.
• W2149633685 creator A5000045670 @default.
• W2149633685 creator A5005673232 @default.
• W2149633685 creator A5016178402 @default.
• W2149633685 creator A5025837736 @default.
• W2149633685 creator A5027561648 @default.
• W2149633685 creator A5042267976 @default.
• W2149633685 creator A5046793050 @default.
• W2149633685 creator A5057352435 @default.
• W2149633685 creator A5072191588 @default.
• W2149633685 creator A5073800105 @default.
• W2149633685 creator A5075994556 @default.
• W2149633685 creator A5079259073 @default.
• W2149633685 creator A5080237153 @default.
• W2149633685 creator A5081984310 @default.
• W2149633685 date "2014-07-01" @default.
• W2149633685 modified "2023-10-09" @default.
• W2149633685 title "Use of Renin-Angiotensin Inhibitors in People with Renal Artery Stenosis" @default.
• W2149633685 cites W1560486856 @default.
• W2149633685 cites W1968515316 @default.
• W2149633685 cites W1976834810 @default.
• W2149633685 cites W1980952050 @default.
• W2149633685 cites W1984799912 @default.
• W2149633685 cites W1986248422 @default.
• W2149633685 cites W1986924251 @default.
• W2149633685 cites W1998008973 @default.
• W2149633685 cites W1999498031 @default.
• W2149633685 cites W2007242346 @default.
• W2149633685 cites W2013715264 @default.
• W2149633685 cites W2023187387 @default.
• W2149633685 cites W2040254335 @default.
• W2149633685 cites W2040993595 @default.
• W2149633685 cites W2044491252 @default.
• W2149633685 cites W2058589233 @default.
• W2149633685 cites W2064099037 @default.
• W2149633685 cites W2070276628 @default.
• W2149633685 cites W2078949740 @default.
• W2149633685 cites W2084343172 @default.
• W2149633685 cites W2086524451 @default.
• W2149633685 cites W2088521765 @default.
• W2149633685 cites W2110320764 @default.
• W2149633685 cites W2113760558 @default.
• W2149633685 cites W2115855000 @default.
• W2149633685 cites W2130283749 @default.
• W2149633685 cites W2130912008 @default.
• W2149633685 cites W2133186334 @default.
• W2149633685 cites W2141640685 @default.
• W2149633685 cites W2156121263 @default.
• W2149633685 cites W2161018612 @default.
• W2149633685 cites W2164686035 @default.
• W2149633685 cites W2171223472 @default.
• W2149633685 cites W2178738676 @default.
• W2149633685 cites W2477567742 @default.
• W2149633685 cites W3021250193 @default.
• W2149633685 doi "https://doi.org/10.2215/cjn.11611113" @default.
• W2149633685 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4078968" @default.
• W2149633685 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24903387" @default.
• W2149633685 hasPublicationYear "2014" @default.
• W2149633685 type Work @default.
• W2149633685 sameAs 2149633685 @default.
• W2149633685 citedByCount "28" @default.
• W2149633685 countsByYear W21496336852014 @default.
• W2149633685 countsByYear W21496336852016 @default.
• W2149633685 countsByYear W21496336852017 @default.
• W2149633685 countsByYear W21496336852018 @default.
• W2149633685 countsByYear W21496336852019 @default.
• W2149633685 countsByYear W21496336852021 @default.
• W2149633685 countsByYear W21496336852022 @default.
• W2149633685 countsByYear W21496336852023 @default.
• W2149633685 crossrefType "journal-article" @default.
• W2149633685 hasAuthorship W2149633685A5000045670 @default.
• W2149633685 hasAuthorship W2149633685A5005673232 @default.
• W2149633685 hasAuthorship W2149633685A5016178402 @default.
• W2149633685 hasAuthorship W2149633685A5025837736 @default.
• W2149633685 hasAuthorship W2149633685A5027561648 @default.
• W2149633685 hasAuthorship W2149633685A5042267976 @default.
• W2149633685 hasAuthorship W2149633685A5046793050 @default.
• W2149633685 hasAuthorship W2149633685A5057352435 @default.
• W2149633685 hasAuthorship W2149633685A5072191588 @default.
• W2149633685 hasAuthorship W2149633685A5073800105 @default.
• W2149633685 hasAuthorship W2149633685A5075994556 @default.
• W2149633685 hasAuthorship W2149633685A5079259073 @default.
• W2149633685 hasAuthorship W2149633685A5080237153 @default.
• W2149633685 hasAuthorship W2149633685A5081984310 @default.
• W2149633685 hasBestOaLocation W21496336851 @default.
• W2149633685 hasConcept C104849204 @default.
• W2149633685 hasConcept C126322002 @default.
• W2149633685 hasConcept C126894567 @default.
• W2149633685 hasConcept C134018914 @default.
• W2149633685 hasConcept C159641895 @default.
• W2149633685 hasConcept C164705383 @default.
• W2149633685 hasConcept C198710026 @default.
• W2149633685 hasConcept C27016395 @default.
• W2149633685 hasConcept C2776634560 @default.
• W2149633685 hasConcept C2778198053 @default.
• W2149633685 hasConcept C2779611605 @default.
• W2149633685 hasConcept C2780091579 @default.

• next